Survival rates in T1 and T2 gastric cancer: A Western report

Journal of Surgical Oncology

Volumn 114, Issue 5, 2016, Pages 602-606

  Ikoma, Naruhiko ^a   Blum, Mariela ^a   Chiang, Yi Ju ^a   Estrella, Jeannelyn S ^a   Roy Chowdhuri, Sinchita ^a   Fournier, Keith ^a   Mansfield, Paul ^a   Ajani, Jaffer A ^a   Badgwell, Brian D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

gastric cancer; race; survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADJUVANT CHEMOTHERAPY; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; CANCER GRADING; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; ESOPHAGEAL ADENOCARCINOMA; FEMALE; FOLLOW UP; GASTRECTOMY; GASTROESOPHAGEAL JUNCTION; HISPANIC; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PARTIAL GASTRECTOMY; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; TOTAL STOMACH RESECTION; WIDE EXCISION; ADENOCARCINOMA; CANCER STAGING; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; STOMACH NEOPLASMS; SURVIVAL RATE; TEXAS; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TEXAS; TREATMENT OUTCOME;

EID: 84992159149     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.24382     Document Type: Article

References (27)

1. Hartgrink HH, Jansen EP, van Grieken NC, et al.: Gastric cancer. Lancet 2009; 374:477–490.
2. Ono H, Kondo H, Gotoda T, et al.: Endoscopic mucosal resection for treatment of early gastric cancer. Gut 2001; 48:225–229.
3. Everett SM, Axon AT: Early gastric cancer in Europe. Gut 1997; 41:142–150.
4. Kondo A, de Moura EG, Bernardo WM, et al.: Endoscopy vs surgery in the treatment of early gastric cancer: Systematic review. World J Gastroenterol 2015; 21:13177–13187.
5. Meng FS, Zhang ZH, Wang YM, et al.: Comparison of endoscopic resection and gastrectomy for the treatment of early gastric cancer: A meta-analysis. Surg Endosc 2015 [Epub ahead of print].
6. Etoh T, Katai H, Fukagawa T, et al.: Treatment of early gastric cancer in the elderly patient: Results of EMR and gastrectomy at a national referral center in Japan. Gastrointest Endosc 2005; 62:868–871.
7. Lee H, Yun WK, Min BH, et al.: A feasibility study on the expanded indication for endoscopic submucosal dissection of early gastric cancer. Surg Endosc 2011; 25:1985–1993.
8. Ajani JA, Winter K, Okawara GS, et al.: Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): Quality of combined modality therapy and pathologic response. J Clin Oncol 2006; 24:3953–3958.
9. Badgwell B, Cormier JN, Krishnan S, et al.: Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol 2008; 15:2684–2691.
10. Macdonald JS, Smalley SR, Benedetti J, et al.: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. New Engl J Med 2001; 345:725–730.
11. Sakuramoto S, Sasako M, Yamaguchi T, et al.: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. New Eng J Med 2007; 357:1810–1820.
12. Cunningham D, Allum WH, Stenning SP, et al.: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New Engl J Med 2006; 355:11–20.
13. Washington K: 7th edition of the AJCC cancer staging manual: Stomach. Ann Surg Oncol 2010; 17:3077–3079.
14. de Gara CJ, Hanson J, Hamilton S: A population-based study of tumor-node relationship, resection margins, and surgeon volume on gastric cancer survival. Am J Surg 2003; 186:23–27.
15. Hochwald SN, Brennan MF, Klimstra DS, et al.: Is lymphadenectomy necessary for early gastric cancer? Ann Surg Oncol 1999; 6:664–670.
16. Lee J, Lim do H, Kim S, et al.: Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: The ARTIST trial. J Clin Oncol 2012; 30:268–273.
17. Nakajima T, Nashimoto A, Kitamura M, et al.: Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: A randomised trial. Gastric Cancer Surgical Study Group. Lancet 1999; 354:273–277.
18. Bang YJ, Kim YW, Yang HK, et al.: Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): A phase 3 open-label, randomised controlled trial. Lancet 2012; 379:315–321.
19. Siewert JR: Gastric cancer: The dispute between East and West. Gastric Cancer 2005; 8:59–61.
20. Hanyu T, Matsuki A, Kosugi S, et al.: Prognostic analysis of submucosa-invasive gastric cancer with lymph node metastasis. Surgery 2015; 157:716–722.
21. Hirasawa T, Gotoda T, Miyata S, et al.: Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer 2009; 12:148–152.
22. Kwee RM, Kwee TC: Predicting lymph node status in early gastric cancer. Gastric Cancer 2008; 11:134–148.
23. Jatzko G, Lisborg PH, Klimpfinger M: Extended lymphadenectomy against early gastric cancer. Jpn J Clin Oncol 1992; 22:26–29.
24. Ahmad R, Setia N, Schmidt BH, et al.: Predictors of lymph node metastasis in western early gastric cancer. J Gastrointest Surg 2016; 20:531–538.
25. Fukuhara S, Yabe M, Montgomery MM, et al.: Race/Ethnicity is predictive of lymph node status in patients with early gastric cancer. J Gastroint Surg 2014; 18:1744–1751.
26. Choi KK, Bae JM, Kim SM, et al.: The risk of lymph node metastases in 3951 surgically resected mucosal gastric cancers: Implications for endoscopic resection. Gastrointest Endosc 2016; 83:896–901.
27. Choi AH, Nelson RA, Merchant SJ, et al.: Rates of lymph node metastasis and survival in T1a gastric adenocarcinoma in western populations. Gastrointest Endosc 2016; 83:1184–1192.